Invicta Diagnostic Limited (NSE:INVICTA)
India flag India · Delayed Price · Currency is INR
74.35
+1.35 (1.85%)
At close: Jan 19, 2026

Invicta Diagnostic Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Net Income
48.9237.61---
Depreciation & Amortization
24.8719.21---
Other Amortization
0.040.12---
Other Operating Activities
19.7314.31---
Change in Accounts Receivable
-6.01-8.5---
Change in Inventory
-1.09-3.94---
Change in Accounts Payable
-10.3411.49---
Change in Other Net Operating Assets
-10.53-6.69---
Operating Cash Flow
65.5963.62---
Operating Cash Flow Growth
3.10%----
Capital Expenditures
-5.56-84.78---
Sale of Property, Plant & Equipment
2.29----
Investment in Securities
-43.34----
Other Investing Activities
-5.69-1.2---
Investing Cash Flow
-52.3-85.98---
Long-Term Debt Issued
-38.01---
Long-Term Debt Repaid
-2.73----
Net Debt Issued (Repaid)
-2.7338.01---
Issuance of Common Stock
-9.33---
Other Financing Activities
-2.3-12.07---
Financing Cash Flow
-5.0335.28---
Net Cash Flow
8.2612.92---
Free Cash Flow
60.03-21.16---
Free Cash Flow Margin
19.89%-13.31%---
Free Cash Flow Per Share
7.13-2.51---
Cash Interest Paid
2.31.01---
Levered Free Cash Flow
46.72-11.82---
Unlevered Free Cash Flow
47.72-11.45---
Change in Working Capital
-27.97-7.64---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.